PET tracer for imaging of neuroendocrine tumors

Palle Rasmussen (Inventor), Ulrich Knigge (Inventor), Liselotte Hølgård (Inventor), Andreas Kjær (Inventor)

    Research output: Patent

    78 Downloads (Pure)


    There is provided a radiolabelled peptide-based compound for diagnostic imaging using positron emission tomography (PET). The compound may thus be used for diagnosis of malignant diseases. The compound is particularly useful for imaging of somatostatin overexpression in tumors, wherein the compound is capable of being imaged by PET when administered with a target dose in the range of 150-350 MBq, such as 150-250 MBq, preferable in the range of 191-210 MBq.
    Original languageEnglish
    IPCA61K38/08; A61K51/08
    Patent numberWO2013029616
    Filing date31/08/2011
    Country/TerritoryInternational Bureau of the World Intellectual Property Organization (WIPO)
    Publication statusPublished - 2013


    Dive into the research topics of 'PET tracer for imaging of neuroendocrine tumors'. Together they form a unique fingerprint.

    Cite this